MeiraGTx Holdings (MGTX) Change in Receivables (2020 - 2025)
MeiraGTx Holdings (MGTX) reported Change in Receivables of $2.5 million for Q4 2025, down 39.25% on a YoY basis from $4.1 million in Q4 2024, and down 46.67% quarter-over-quarter from $4.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Change in Receivables (2020 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Change in Receivables for 6 years, with the latest figure at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 39.25% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 157.63% YoY), and the FY2025 full-year result was $2.3 million, up 157.63% from the prior year.
- Change in Receivables for Q4 2025 stood at $2.5 million, down from $4.7 million in the prior quarter.
- The five-year high for Change in Receivables was $42.2 million in Q3 2021, with the low at -$26.8 million in Q1 2021.
- Historically, Change in Receivables has averaged $825368.4 across 5 years, with a median of $1.6 million in 2024.
- The largest YoY upside for Change in Receivables was 1528.67% in 2021 against a maximum downside of 668.72% in 2021.
- MeiraGTx Holdings' Change in Receivables stood at -$5.1 million in 2021, then surged by 146.71% to $2.4 million in 2022, then surged by 108.07% to $5.0 million in 2023, then dropped by 16.87% to $4.1 million in 2024, then sank by 39.25% to $2.5 million in 2025.
- The last three Change in Receivables figures came in at $2.5 million (Q4 2025), $4.7 million (Q3 2025), and -$4.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | -4.85 Mn |
| Mar 31, 2025 | -4.85 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | -11.19 Mn |
| Jun 30, 2024 | -11.19 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | -10.35 Mn |
| Sep 30, 2023 | -10.35 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.59 Mn |